Unknown

Dataset Information

0

Paroxysmal hypnogenic dyskinesia is associated with mutations in the PRRT2 gene.


ABSTRACT: To explore the potential causative genes of paroxysmal hypnogenic dyskinesia (PHD), which was initially considered a subtype of paroxysmal dyskinesia and has been recently considered a form of nocturnal frontal lobe epilepsy (NFLE).Eleven patients with PHD were recruited. Mutations in proline-rich region transmembrane protein-2 (PRRT2), myofibrillogenesis regulator 1 (MR-1), solute carrier family 2, member 1 (SLC2A1), calcium-activated potassium channel alpha subunit (KCNMA1), cholinergic receptor, nicotinic, alpha 4 (CHRNA4), cholinergic receptor, nicotinic, beta 2 (CHRNB2), cholinergic receptor, nicotinic, alpha 2 (CHRNA2), and potassium channel subfamily T member 1 (KCNT1) were screened by direct sequencing.Two PRRT2 mutations were identified in patients with typical PHD. A mutation of c.649dupC (p.Arg217ProfsX8) was identified in a patient with PHD and his father who was diagnosed with paroxysmal kinesigenic dyskinesia. An additional mutation of c.640G>C (p.Ala214Pro) was identified in a sporadic patient and his asymptomatic mother. No mutations were found in the other screened genes.The present study identified PRRT2 mutations in PHD, extending the phenotypic spectrum of PRRT2 and supporting the classification of PHD as a subtype of paroxysmal dyskinesia but not NFLE. Based on the results of this study, screening for the PRRT2 mutation is recommended in patients with PHD.

SUBMITTER: Liu XR 

PROVIDER: S-EPMC4830198 | biostudies-other | 2016 Apr

REPOSITORIES: biostudies-other

altmetric image

Publications


<h4>Objective</h4>To explore the potential causative genes of paroxysmal hypnogenic dyskinesia (PHD), which was initially considered a subtype of paroxysmal dyskinesia and has been recently considered a form of nocturnal frontal lobe epilepsy (NFLE).<h4>Methods</h4>Eleven patients with PHD were recruited. Mutations in proline-rich region transmembrane protein-2 (PRRT2), myofibrillogenesis regulator 1 (MR-1), solute carrier family 2, member 1 (SLC2A1), calcium-activated potassium channel alpha su  ...[more]

Similar Datasets

| S-EPMC8370144 | biostudies-literature
| S-EPMC6995733 | biostudies-literature
| S-EPMC3334308 | biostudies-literature
| S-EPMC3511930 | biostudies-literature
| S-EPMC3098736 | biostudies-literature
| S-EPMC3511926 | biostudies-literature
| S-EPMC7469858 | biostudies-literature
| S-EPMC3409860 | biostudies-literature
2021-03-12 | GSE166712 | GEO
| S-EPMC8437987 | biostudies-literature